SCHEDULE: Vincent Smith Boosts Adagene Stake to 8.7%
Beneficial Ownership Statement
Vincent C. Smith and affiliated entities have reported an aggregate beneficial ownership of 8.7% of Adagene Inc.'s Ordinary Shares.
Summary
- Vincent C. Smith, The Vincent C. Smith, Jr. 2025 Annuity Trust, and VCS Master Holdings GP are the reporting persons for this Schedule 13G amendment.
- Collectively, Vincent C. Smith may be deemed to beneficially own an aggregate of 5,095,351.25 Ordinary Shares of Adagene Inc.
- This aggregate ownership represents 8.7% of the Issuer's Ordinary Shares outstanding, based on 58,914,087 Ordinary Shares as of June 30, 2025.
- Mr. Smith directly holds 1,301,631.25 Ordinary Shares with sole voting and dispositive power.
- The Vincent C. Smith, Jr. 2025 Annuity Trust holds 3,608,018.75 Ordinary Shares, representing 6.1% of the class, with shared voting and dispositive power.
- VCS Master Holdings GP holds 185,701.25 Ordinary Shares, representing 1.0% of the class, also with shared voting and dispositive power.
- Mr. Smith is a trustee of The Vincent C. Smith, Jr. 2025 Annuity Trust and the grantor of trusts that are partners of VCS Master Holdings GP, leading to his deemed beneficial ownership of these shares.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive signal, as a significant beneficial ownership stake by an individual and associated trusts can imply confidence in the company's long-term prospects, though it's a passive investment disclosure.
Positives
- Significant beneficial ownership by Vincent C. Smith and affiliated entities, totaling 8.7% of Adagene Inc.'s Ordinary Shares, indicates a notable investment and potential confidence in the company.
Future Outlook
This filing is a disclosure of beneficial ownership and does not contain any forward-looking statements or guidance from Adagene Inc. or the reporting persons regarding the company's future performance.
Industry Context
StockSavvy.ai notes that significant individual or institutional stakes, such as this 8.7% ownership in Adagene Inc., often draw attention in the biotechnology sector, signaling potential long-term interest or a belief in the company's strategic direction or pipeline.
Stakeholder Impact
- Shareholders: Increased transparency regarding significant ownership, potentially signaling confidence from a notable investor.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of Issuer's Ordinary Shares outstanding used for percentage calculation (58,914,087 shares). |
| 10/31/2025 | Date of Issuer's Registration Statement on Form F-1, which provided the outstanding share count. |
| 12/31/2025 | Date of event which requires filing of this statement. |
| 01/29/2026 | Date of filing and signature by reporting persons. |
Recommendation
holdThe filing indicates a substantial beneficial ownership stake by Vincent C. Smith and affiliated entities, representing 8.7% of Adagene Inc.'s Ordinary Shares. This level of ownership suggests a long-term interest and potential confidence from a significant investor. However, a Schedule 13G is a passive ownership disclosure and does not provide operational or financial performance details that would warrant a stronger recommendation. Investors should hold and monitor for further developments or operational updates from Adagene Inc.
Keywords
Adagene Inc., ADAG, Vincent C. Smith, beneficial ownership, Schedule 13G, Ordinary Shares, institutional ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.